Thyroid disease

Echogenicity as a standalone nodule characteristic is not inferior to the TN image reporting and data systems (TIRADS) systems in the 10–20 mm nodule diameter range in patient selection for fine needle aspiration: a pilot study

Eur Thyroid JPublished Diagnostic accuracy study

Authors' conclusion

In contrast to >20 mm diameter nodules, the recommendation of FNA may rely on a single US feature, echogenicity, in the 10-20 mm size range. If independently confirmed in larger cohorts, this may simplify nodule evaluation in this size range.

Study context

Population
Histologically verified thyroid nodules evaluated on ultrasound (US) video recordings for fine needle aspiration (FNA) selection; nodules ≥10 mm110 nodules ≥10 mm analysed
Participants
123 participants
Comparison
Echogenicity alone vs five TIRADS systems
Outcome
Sensitivity and specificity for identifying malignant nodules (indication for FNA)
Methodological detailspilot study, online video evaluation by seven experienced investigators, four countries, histologically verified nodules
  • Pilot study
  • Online video evaluation by seven experienced investigators
  • Four countries
  • Histologically verified nodules

Performance

As reported in the abstract

Identification of malignant nodules, 10-20 mm size range
Test or modelSensitivitySpecificity
TIRADS80.5-91.0%31.4-50.9%
Echogenicity87.5%43.4%

Sensitivity

TIRADS80.5-91.0%
Echogenicity87.5%

Specificity

TIRADS31.4-50.9%
Echogenicity43.4%

Further findings

10-20 mm vs >20 mm

Proportion of cancers that were hypoechoic: 10-20 mm vs >20 mm nodules

P = 0.05

Isoechoic vs Hypoechoic

Proportion of nodules with suspicious findings, 10-20 mm: hypoechoic vs isoechoic · significantly lower with isoechoic

P < 0.05

Original publication

Echogenicity as a standalone nodule characteristic is not inferior to the TIRADS systems in the 10–20 mm nodule diameter range in patient selection for fine needle aspiration: a pilot study. Eur Thyroid J. Published 6 November 2024. doi:10.1530/etj-24-0149

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.